122 related articles for article (PubMed ID: 16552334)
1. Differential kinetics of plasma CD105 and transforming growth factor beta expression early in human acute pancreatitis.
Jamdar S; Al-Mowallad AF; Kumar S; Siriwardena AK
Pancreas; 2006 Mar; 32(2):152-8. PubMed ID: 16552334
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
[TBL] [Abstract][Full Text] [Related]
3. Functional role of CD105 in TGF-beta1 signalling in murine and human endothelial cells.
Warrington K; Hillarby MC; Li C; Letarte M; Kumar S
Anticancer Res; 2005; 25(3B):1851-64. PubMed ID: 16158917
[TBL] [Abstract][Full Text] [Related]
4. Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
Bozas G; Terpos E; Gika D; Karadimou A; Dimopoulos MA; Bamias A
Int J Gynecol Cancer; 2010 Feb; 20(2):248-54. PubMed ID: 20134268
[TBL] [Abstract][Full Text] [Related]
5. Plasma CD105, TGFbeta-1, TGFbeta-3 and the ligand/receptor complexes in children with acute lymphoblastic leukaemia.
Al-Mowallad A; Carr T; Al-Qouzi A; Li C; Byers R; Kumar S
Anticancer Res; 2006; 26(1B):543-7. PubMed ID: 16739317
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis.
Li C; Wilson PB; Levine E; Barber J; Stewart AL; Kumar S
Int J Cancer; 1999 Apr; 84(2):155-9. PubMed ID: 10096248
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of soluble CD105 correlate with metastasis in patients with breast cancer.
Li C; Guo B; Wilson PB; Stewart A; Byrne G; Bundred N; Kumar S
Int J Cancer; 2000 Mar; 89(2):122-6. PubMed ID: 10754488
[TBL] [Abstract][Full Text] [Related]
8. TNF alpha down-regulates CD105 expression in vascular endothelial cells: a comparative study with TGF beta 1.
Li C; Guo B; Ding S; Rius C; Langa C; Kumar P; Bernabeu C; Kumar S
Anticancer Res; 2003; 23(2B):1189-96. PubMed ID: 12820370
[TBL] [Abstract][Full Text] [Related]
9. Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.
Altomonte M; Montagner R; Fonsatti E; Colizzi F; Cattarossi I; Brasoveanu LI; Nicotra MR; Cattelan A; Natali PG; Maio M
Br J Cancer; 1996 Nov; 74(10):1586-91. PubMed ID: 8932339
[TBL] [Abstract][Full Text] [Related]
10. Synergy between anti-endoglin (CD105) monoclonal antibodies and TGF-beta in suppression of growth of human endothelial cells.
She X; Matsuno F; Harada N; Tsai H; Seon BK
Int J Cancer; 2004 Jan; 108(2):251-7. PubMed ID: 14639611
[TBL] [Abstract][Full Text] [Related]
11. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1.
Letarte M; McDonald ML; Li C; Kathirkamathamby K; Vera S; Pece-Barbara N; Kumar S
Cardiovasc Res; 2005 Oct; 68(1):155-64. PubMed ID: 15907823
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 and CD105 promote the migration of hepatocellular carcinoma-derived endothelium.
Benetti A; Berenzi A; Gambarotti M; Garrafa E; Gelati M; Dessy E; Portolani N; Piardi T; Giulini SM; Caruso A; Invernici G; Parati EA; Nicosia R; Alessandri G
Cancer Res; 2008 Oct; 68(20):8626-34. PubMed ID: 18922939
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas.
Netto GC; Bleil CB; Hilbig A; Coutinho LM
Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830
[TBL] [Abstract][Full Text] [Related]
14. Differential levels of soluble endoglin (CD105) in myeloid malignancies.
Calabrò L; Fonsatti E; Bellomo G; Alonci A; Colizzi F; Sigalotti L; Altomonte M; Musolino C; Maio M
J Cell Physiol; 2003 Feb; 194(2):171-5. PubMed ID: 12494455
[TBL] [Abstract][Full Text] [Related]
15. CD105 (endoglin) expression on hematopoietic stem/progenitor cells.
Pierelli L; Bonanno G; Rutella S; Marone M; Scambia G; Leone G
Leuk Lymphoma; 2001; 42(6):1195-206. PubMed ID: 11911400
[TBL] [Abstract][Full Text] [Related]
16. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression.
Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A
Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
Pappa CA; Alexandrakis MG; Boula A; Psarakis FE; Kolovou A; Bantouna V; Stavroulaki E; Tsirakis G
Hematol Oncol; 2013 Dec; 31(4):201-5. PubMed ID: 23576184
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-betas and CD105 expression in calcification and bone formation in human atherosclerotic lesions.
Jeziorska M
Z Kardiol; 2001; 90 Suppl 3():23-6. PubMed ID: 11374028
[TBL] [Abstract][Full Text] [Related]
19. Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.
Li C; Gardy R; Seon BK; Duff SE; Abdalla S; Renehan A; O'Dwyer ST; Haboubi N; Kumar S
Br J Cancer; 2003 May; 88(9):1424-31. PubMed ID: 12778073
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer's disease patients.
Juraskova B; Andrys C; Holmerova I; Solichova D; Hrnciarikova D; Vankova H; Vasatko T; Krejsek J
J Nutr Health Aging; 2010 Nov; 14(9):758-61. PubMed ID: 21085906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
